FDA approves mini version of RECELL GO for smaller wounds
Avita’s RECELL platform uses the regenerative properties of the patient’s own skin for wound treatment.
Treatments
Signati submits De Novo application to FDA after completing trial
Inquis Medical secures $40m funding to advance thrombectomy system
Fish-skin grafts outperform current treatments in diabetic foot ulcers
eGenesis scoops $191m for genetically modified pig kidney transplant trial
Spectral AI hits enrollment goal at burn centres for AI-powered assessment tech
AA Medical acquires Surgical Product Solutions
Signati kicks off trial investigating quicker vasectomy device
